Correction to: How Does the Public Evaluate Vaccines for Low­Incidence, Severe­Outcome Diseases? A General­Population Choice Experiment.

Reed Johnson, F; Fairchild, Angelyn; Whittington, Dale; Srivastava, Amit K; Gonzalez, Juan Marcos; Huang, Liping

Correction to: How Does the Public Evaluate Vaccines for LowIncidence, SevereOutcome Diseases? A GeneralPopulation Choice Experiment.

Reed Johnson, F; Fairchild, Angelyn; Whittington, Dale; Srivastava, Amit K; Gonzalez, Juan Marcos; Huang, Liping.

Afiliación

Reed Johnson F; Duke Clinical Research Institute, Duke University, 300 West Morgan Street, Durham, NC, 27701, USA. reed.johnson@duke.edu.
Fairchild A; Angelyn Fairchild Kenan-Flagler School of Business, University of North Carolina, Chapel Hill, NC, USA.
Whittington D; Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
Srivastava AK; Global Development Institute, University of Manchester, Manchester, UK.
Gonzalez JM; Medical Development and Scientifc Clinical Afairs, Pfzer Vaccines, Collegeville, PA, USA.
Huang L; Orbital Therapeutics, Cambridge, MA, USA.

Patient ; 16(3): 287, 2023 May.

Article en En | MEDLINE | ID: mdl-36913118

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Incidence_studies / Risk_factors_studies Idioma: En Revista: Patient Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google